Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases

Authors
Category Primary study
JournalKidney International Reports
Year 2023
This article has no abstract
Epistemonikos ID: c3a82d3ffb8935a03120a70c759b440667893fdc
First added on: Feb 16, 2025